Taiho Pharmaceutical begins enrolling patients in phase II study of TAC-302 Aug. 11, 2017 No Comments
FDA grants orphan drug designation for blisibimod as treatment of IgA nephropathy Aug. 10, 2017 No Comments
Quark Pharmaceuticals reports positive results from QPI-1002 phase II study July 28, 2017 No Comments
RSS